Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 2/2011

Ausgabe 2/2011

Inhaltsverzeichnis ( 20 Artikel )

01.06.2011 | Editorial | Ausgabe 2/2011

Gastrointestinal cancers – still many questions to be resolved

E. Wöll

01.06.2011 | Editorial | Ausgabe 2/2011

ASH 2010: new drugs and novel therapeutic concepts on the move

M. Steurer

01.06.2011 | CECOG News | Ausgabe 2/2011

CECOG/BC1.2.001 – International Clinical Trials Workshop, July 1–2, Cluj-Napoca

Dagmar Just

01.06.2011 | Review | Ausgabe 2/2011

Current treatment strategies of oesophageal carcinoma

T. Ruhstaller, M. Stahl

01.06.2011 | Review | Ausgabe 2/2011

Gastric cancer – still many questions to be solved

F. Lordick, G. Schumacher, M. Becker-Schiebe

01.06.2011 | Short Review | Ausgabe 2/2011

Recent developments and future perspectives in the systemic treatment of metastatic colorectal cancer

O. Coutelle, M. Hallek, U. T. Hacker

01.06.2011 | Short Review | Ausgabe 2/2011

Bowel First? Simultaneous Resection? Liver First? Treatment options in patients with colorectal cancer and resectable synchronous liver metastases

M. Zitt

01.06.2011 | Short Review | Ausgabe 2/2011

Can stereotactic radiofrequency ablation replace liver resection?

R. Bale, G. Widmann

01.06.2011 | Short Review | Ausgabe 2/2011

Adjuvant chemotherapy in colon carcinoma stages II and III

G. Resch, J. Thaler

01.06.2011 | Short Review | Ausgabe 2/2011

(Neo-)Adjuvant radiochemotherapy in stage II/III rectal cancer

W. Hoffmann, F. Lordick, M. Becker-Schiebe

01.06.2011 | Short Review | Ausgabe 2/2011

Recent advances and future challenges in the treatment of hepatocellular and biliary tract carcinomas

D. Koeberle, P. Samaras

01.06.2011 | Short Review | Ausgabe 2/2011

Side effect management during treatment of gastrointestinal (GI) cancers

M. Becker-Schiebe, F. Lordick, W. Hoffmann

01.06.2011 | Short Review | Ausgabe 2/2011

Contribution of PET-CT in the management of gastrointestinal cancer

M. Gabriel

01.06.2011 | ASH Report | Ausgabe 2/2011

Novel Developments in AML – ASH 2010

W. R. Sperr, P. Valent

01.06.2011 | ASH Report | Ausgabe 2/2011

Myelodysplastic Syndromes (MDS) – News from ASH 2010

T. Nösslinger, M. Pfeilstöcker

01.06.2011 | ASH Report | Ausgabe 2/2011

Indolent lymphomas and mantle cell lymphoma: New developments as of ASH 2010

J. Drach

01.06.2011 | ASH Report | Ausgabe 2/2011

Multiple myeloma at ASH 2010: Some points that might change our daily practice

E. Gunsilius, W. Willenbacher

01.06.2011 | ASH Report | Ausgabe 2/2011

ASH update 2010: Chronic lymphocytic leukaemia

M. Steurer, S. Schmidt

01.06.2011 | ASH Report | Ausgabe 2/2011

Novel agents in diffuse large B-cell lymphoma: A short update including ASH 2010

T. Melchardt, S. W. Hofbauer, R. Greil, G. Hopfinger

01.06.2011 | ASH Report | Ausgabe 2/2011

What's new in CML? Highlights of ASH 2010

J. Rudzki, D. Wolf

Aktuelle Ausgaben